Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1

Microvascular injury, oxidative stress, and impaired angiogenesis are prominent features of systemic sclerosis (SSc). We compared serum markers of these phenomena at baseline and after treatment with nifedipine in SSc patients. Forty successive SSc patients were compared with 20 matched healthy subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Allanore, Yannick, Borderie, Didier, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC464873/
https://www.ncbi.nlm.nih.gov/pubmed/15225366
http://dx.doi.org/10.1186/ar1183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC464873/
https://www.ncbi.nlm.nih.gov/pubmed/15225366
http://dx.doi.org/10.1186/ar1183

Ejemplares similares